Author

Xin Du

Beijing University of Chinese MedicineORCID 0000-0002-9004-8758Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xin Du1 paper

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Chengxiang XiaiD· 2 shared Dehao HuangiD· 2 shared Fangxiao HuiD· 2 shared Jinyong WangiD· 2 shared Mengyun ZhangiD· 2 shared Qitong WengiD· 2 shared Tongjie WangiD· 2 shared Yunqing LiniD· 2 shared

Activity by Year

2020-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Chengxiang XiaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyJournal for ImmunoTherapy of CancerPeer-reviewedSep 1, 2025

CD33KO-CD33-mesothelin loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia

Yao Wang, Xiujuan Zheng, Zhiqian Wang…·Jinyong Wang

This study designs a CD33-mesothelin loop CAR to enhance iNK cell efficacy against AML by avoiding fratricide and improving cytotoxicity.

6 citations

𝕏 PostBluesky

Cell BiologybioRxivPreprintJul 30, 2024

Efficient generation of CAR NK cells from human umbilical cord blood CD34+ stem and progenitors for democratizing affordable immunotherapy

Jianhuan Li, Yao Wang, Xiujuan Zheng…·Jinyong Wang

This study develops a three-step method to generate high-yield CAR NK cells from umbilical cord blood CD34+ HSPCs, reducing CAR engineering costs and enabling therapeutic applications.

DOI 10.1101/2024.07.30.605741

humanexperimental assay

𝕏 PostBluesky

NeurosciencebioRxivPreprintFeb 28, 2020

Exploring the Pharmacological Mechanism of Bezoar on Cerebral Ischemic Stroke using a Network Pharmacology Approach

Xin Du, Changxiang Li, Beida Ren…·Min Wang

This study uses network pharmacology to identify 48 potential targets and 3 signaling pathways involved in bezoar's mechanism of action for treating ischemic stroke.

DOI 10.1101/2020.02.28.969436

statistical modelgene regulatory network inference

𝕏 PostBluesky